S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
New CBOE “special perk” helps traders target income every weekend (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
New CBOE “special perk” helps traders target income every weekend (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
New CBOE “special perk” helps traders target income every weekend (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
New CBOE “special perk” helps traders target income every weekend (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund

Corindus Vascular Robotics Stock Price, News & Analysis (NYSEAMERICAN:CVRS)

$4.27
0.00 (0.00%)
(As of 11/27/2019)
Compare
Today's Range
$4.27
▼
$4.27
50-Day Range
N/A
52-Week Range
$0.78
▼
$4.40
Volume
N/A
Average Volume
1.99 million shs
Market Capitalization
$891.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CVRS stock logo

About Corindus Vascular Robotics Stock (NYSEAMERICAN:CVRS)

Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures. Its CorPath system allows the physician to perform procedures with a control console located within an interventional cockpit; and CorPath GRX system enables the precise robotic-assisted control of guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit. The company sells its products through direct sales force, as well as through distributor and partnership relationships. It serves vascular, coronary, peripheral vascular, neurointerventional, and structural heart markets. Corindus Vascular Robotics, Inc. is headquartered in Waltham, Massachusetts.

CVRS Stock Price History

CVRS Stock News Headlines

May 28, 2023 | forbes.com
Robotics, AI And Cognitive Computing Are Changing Organizations Even Faster Than We Thought
April 21, 2023 | marketwatch.com
2023-2030 Robotic Vascular Catheter System Market Size with [94 Pages] includes Growth Rate Analysis | New Report by Absolute Reports
December 6, 2023 | Autonomix (Ad)
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
March 2, 2023 | techcrunch.com
Robotics & AI
January 29, 2023 | finance.yahoo.com
Ganymed Robotics Raises Additional €15 M through Series B Extension Bringing Total Amount to €36 M
January 17, 2023 | finance.yahoo.com
The Worldwide Industrial Robotics Industry is Expected to Reach $43.9 Billion in 2027
January 5, 2023 | finance.yahoo.com
Monopoly Dreams(TM) and Novelte Robotics Join Forces to Pamper Visitors with Interactive Information & Tour Guide Service - RoboButler
October 9, 2022 | finance.yahoo.com
Robotics as a Service (RaaS) Market to record USD 1.23 Bn incremental growth -- Driven by changes in the global labor force
December 6, 2023 | Autonomix (Ad)
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
September 12, 2022 | apnews.com
Corindus, A Siemens Healthineers Company, Announces Study Results Demonstrating Safety and Effectiveness of CorPath® GRX Neurovascular System
August 30, 2022 | investing.com
CVRS_old Historical Data
April 13, 2022 | finance.yahoo.com
Corindus Announces New Office Opening in Newton to Support Growth
January 5, 2022 | investing.com
Corindus Vascular Robotics Inc (CVRS_old)
November 11, 2021 | apnews.com
IMPULSE DYNAMICS APPOINTS FIVE NEW BOARD MEMBERS
July 7, 2021 | marketwatch.com
Robotic Surgical Devices Market | Industry Analysis, Growth, Price, Report and Forecast 2020-2027
July 6, 2021 | marketwatch.com
Microsurgery Robot Market 2021 Key Trends, Opportunities & Forecasts To 2026
June 29, 2021 | benzinga.com
Surgical Robots Market Research Report by Component, by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
June 25, 2021 | marketwatch.com
Surgical Robots Market Size, Share, Trends, Analysis and Forecast 2027
June 16, 2021 | marketwatch.com
Robotic Catheter System Market Trends 2021 | Industry Growth, Size, Share, Demand and Forecast to 2026
June 15, 2021 | prnewswire.com
Artio Medical Hires Key Sales and Marketing Leaders to Prepare for Commercial Launch of First Product in U.S.
June 11, 2021 | marketwatch.com
Minimal Invasive Surgical Systems Market Size, Major Manufacturers, Production and Market Comparison Analysis up to 2025
June 7, 2021 | markets.businessinsider.com
Leading Interventional Cardiologist Dr. Giora Weisz Joins Microbot Medical’s Scientific Advisory Board
May 14, 2021 | marketwatch.com
Surgical robots market size is expected to reach around US$ 13.7 Bn by 2026 | ARC
May 12, 2021 | benzinga.com
The global surgical robots market is projected to reach USD 14.4 billion by 2026 from USD 6.4 billion in 2021, at a CAGR of 17.6%
May 7, 2021 | uk.finance.yahoo.com
Robotic Surgery Services Global Market Report 2021: COVID 19 Growth And Change to 2030
April 27, 2021 | marketwatch.com
Minimally Invasive Neurosurgical System Market to Garner Growth 11.6% by 2030
April 14, 2021 | marketwatch.com
Minimally Invasive Neurosurgical System Market Size Outlook, Growth, Revenue, Regional Insights and Forecast 2021-2030
See More Headlines
Receive CVRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Corindus Vascular Robotics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/07/2018
Today
12/06/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Industry
Medical Appliances & Equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSEAMERICAN:CVRS
Previous Symbol
NYSEMKT:CVRS
CUSIP
N/A
CIK
N/A
Web
www.corindus.com
Phone
+1-508-6533335
Fax
N/A
Employees
90
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
208,685,000
Free Float
N/A
Market Cap
$891.08 million
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Mark J. Toland (Age 49)
    CEO, Pres & Director
  • Mr. David W. Long (Age 49)
    CFO, Sr. VP, Sec. & Treasurer
  • Mr. Douglas Teany (Age 47)
    Chief Operating Officer
  • Ms. Nora Dutta
    Sr. VP of HR
  • Dr. J. Aaron Grantham
    Chief Medical Officer of Cardiovascular

Key Competitors

View All Competitors














CVRS Stock Analysis - Frequently Asked Questions

How were Corindus Vascular Robotics' earnings last quarter?

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) announced its quarterly earnings data on Tuesday, August, 7th. The medical equipment provider reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.05) by $0.01. The medical equipment provider earned $1.67 million during the quarter, compared to analyst estimates of $3 million.

What other stocks do shareholders of Corindus Vascular Robotics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Corindus Vascular Robotics investors own include Amarin (AMRN), Advanced Micro Devices (AMD), Micron Technology (MU), Alibaba Group (BABA), Helios and Matheson Analytics (HMNY), NVIDIA (NVDA), TherapeuticsMD (TXMD), Ambarella (AMBA) and Exelixis (EXEL).

How do I buy shares of Corindus Vascular Robotics?

Shares of CVRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSEAMERICAN:CVRS) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -